From: Ustanova Iboga <Iboga@guest.arnes.si> Subject: [ibogaine] best wishes Date: December 31, 2002 at 8:06:10 PM EST To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com Hi everybody, we are in 2003 already, and americans are a year behind… Ha ha ha ha!!! Anyway, I wish everyone reading this an IBOgainised 2003! ;-)) Marko From: Gamma…
Continue reading
From: vector6@space.com Subject: Re: [ibogaine] what changed? Date: June 30, 2002 at 11:58:04 PM EDT To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com This is for Kerry not Carrie 🙂 Kerry I don’t know that much about addiction and don’t do any drugs I want to stop doing, I hang at this place because…
Continue reading
From: “preston peet” <ptpeet@nyc.rr.com> Subject: [ibogaine] news links for march 30-31, 2002 @ drugwar.com Date: March 31, 2002 at 4:16:28 PM EST To: “spynews” <spynews@yahoogroups.com> Cc: “rootsofteror” <rootsofterror@yahoogroups.com>, <ibogaine@mindvox.com>, <FreedomNewsNet@aol.com>, “CRRH” <restore@crrh.org>, “cia-drugs” <cia-drugs@yahoogroups.com> Reply-To: ibogaine@mindvox.com Greetings all, Happy Easter, joyous Passover, good Spring Solstice, and to all who practice…
Continue reading
18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…
Continue reading
the Deborah Mash Interview with Paul DeRienzo Dr. Deborah Mash is a faculty member in the Department of Neurology of the University of Miami, School of Medicine with a secondary appointment in Cellular Molecular Pharmacology. Dr. Mash’s area of expertise is called Neuropharmacology and Neuroscience and her doctoral dissertation was…
Continue reading
by Brian Vastag Journal of the American Medical Association Vol. 288 No. 24, pp. 3096-3101, December 25, 2002 © 2002 American Medical Association. All rights reserved. Tabernanthe iboga, the West African source of ibogaine, used by some to treat addiction. New York — Some drugs are made in laboratories. Others,…
Continue reading
Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review By: Jonathan Freedlander Advisor: Carlo DiClemente, Ph.D. University of Maryland, Baltimore County Introduction and History Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubs of the Tabernanthe genus (Obach, Pablo, and Mash, 1998). The root of…
Continue reading